Citadel Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Citadel Advisors's BCAT Position: Q1 2026 in Review
Citadel Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 417% in Q1 2026, buying an estimated $1.07M and bringing the position to 90,136 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #7131.
Citadel Advisors first reported a position in BCAT in Q2 2024 and has held it in 5 quarters since. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- Citadel Advisors held 90,136 shares of BlackRock Capital Allocation Term Trust worth $1.27M as of Q1 2026.
- Citadel Advisors bought 72,687 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $1.07M.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7131 holding.
- Citadel Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2024 and has held it in 5 quarters since.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.